Suppr超能文献

使用新型诊断混合物进行甲基氯异噻唑啉酮/甲基异噻唑啉酮斑贴试验——来自国际接触性皮炎研究组的一项多中心研究。

Patch Testing With Methylchloroisothiazolinone/Methylisothiazolinone Using a New Diagnostic Mix-A Multicenter Study From the International Contact Dermatitis Research Group.

机构信息

From the Department of Occupational and Environmental Dermatology, Skåne University Hospital, Lund University, Malmö, Sweden.

Dermatovenerology and Allergy Centre, Odense University Hospital, University of Southern Denmark.

出版信息

Dermatitis. 2021;32(4):220-224. doi: 10.1097/DER.0000000000000657.

Abstract

BACKGROUND

In the early 1980s, a preservative containing a mixture of methylchloroisothiazolinone (MCI) and methylisothiazolinone (MI) in a ratio of 3:1 was introduced. This mixture (mix) has been patch tested at 100 ppm (0.01%) worldwide and at 200 ppm (0.02%) in Sweden since 1986 and also in the European baseline series since 2014.

OBJECTIVE

A new aqueous mix of MCI 0.015% and MI 0.2% was compared with patch testing with the 2 aqueous baseline preparations of MCI/MI 0.02% and MI 0.2%.

METHODS

Four thousand three hundred ninety-seven patients with dermatitis in 12 International Contact Dermatitis Research Group dermatology departments from 3 continents were patch tested simultaneously with the 3 preparations.

RESULTS

The frequency of positive patch tests to the allergens varied between 0% and 26.7% in the 12 test centers. The new mixture MCI/MI 0.215% in aqua (aq) detected significantly more patients with MCI/MI allergy than both MCI/MI 0.02% aq (P < 0.001) and MI 0.2% aq (P < 0.001) alone and combined.

CONCLUSIONS

The results favor replacing the preparations MCI/MI 0.02% aq and MI 0.2% aq with the mixture MCI/MI 0.215% aq in the International Contact Dermatitis Research Group baseline series.

摘要

背景

20 世纪 80 年代初,引入了一种含有甲基氯异噻唑啉酮(MCI)和甲基异噻唑啉酮(MI)混合物的防腐剂,比例为 3:1。自 1986 年以来,这种混合物(混合)在全球的 100ppm(0.01%)和瑞典的 200ppm(0.02%)进行了斑贴试验,并且自 2014 年以来也在欧洲基线系列中进行了斑贴试验。

目的

将新的 MCI 0.015%和 MI 0.2%的水性混合物与 MCI/MI 0.02%和 MI 0.2%的 2 种水性基线制剂的斑贴试验进行比较。

方法

来自 3 大洲的 12 个国际接触性皮炎研究组皮肤科的 4397 名皮炎患者同时接受了这 3 种制剂的斑贴试验。

结果

在 12 个试验中心,过敏原的阳性斑贴试验频率在 0%至 26.7%之间变化。新的 MCI/MI 0.215%水性混合物比 MCI/MI 0.02%水性混合物(P<0.001)和 MI 0.2%水性混合物(P<0.001)单独和联合检测到更多的 MCI/MI 过敏患者。

结论

结果倾向于用 MCI/MI 0.215%水性混合物替代 MCI/MI 0.02%水性混合物和 MI 0.2%水性混合物,用于国际接触性皮炎研究组的基线系列。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验